Does intraosseous access improve 30-day survival in out-of-hospital cardiac arrests – Full Text

"This study assessed the impact of IO versus intravenous (IV) access on 30-day survival in out-of-hospital cardiac arrests" Newton et al (2025).

"This study assessed the impact of IO versus intravenous (IV) access on 30-day survival in out-of-hospital cardiac arrests" Newton et al (2025).

ReTweet

Does intraosseous access improve 30-day survival in out-of-hospital cardiac arrests

Extract:

“Background: In cardiac arrests, cardiopulmonary resuscitation (CPR), defibrillation and drug administration are time-sensitive interventions. Rapidly securing vascular access in those patients can be challenging, making intraosseous (IO) access a promising option to expedite drug delivery.

Objectives: This study assessed the impact of IO versus intravenous (IV) access on 30-day survival in out-of-hospital cardiac arrests.”

Reference:

Newton H, Godbout J, Vaillancourt C. Does an intraosseous access-first strategy improve 30-day survival in out-of-hospital cardiac arrests? CJEM. 2025 Jul 12. doi: 10.1007/s43678-025-00938-x. Epub ahead of print. PMID: 40650857.